Durvalumab With Chemotherapy Followed by Sequential Radiotherapy for Limited Stage Small Cell Lung Cancer
Condition(s):Limited Stage Small Cell Lung CancerLast Updated:September 5, 2021Recruiting
Hide Studies Not Open or Pending
Condition(s):Limited Stage Small Cell Lung CancerLast Updated:September 5, 2021Recruiting
Condition(s):Small Cell Lung CancerLast Updated:November 21, 2022Not yet recruiting
Condition(s):Limited Stage Small Cell Lung CancerLast Updated:February 13, 2024Not yet recruiting
Condition(s):Small Cell Lung Cancer (SCLC)Last Updated:November 16, 2021Terminated
Condition(s):Small Cell Lung CancerLast Updated:March 17, 2020Completed
Condition(s):Small Cell Lung CancerLast Updated:February 15, 2019Terminated
Condition(s):Small Cell Lung CancerLast Updated:November 6, 2019Completed
Condition(s):Extensive-stage Small Cell Lung CancerLast Updated:December 20, 2018Unknown status
Condition(s):Small Cell Lung Cancer; Radiotherapy; ThymalfasinLast Updated:March 21, 2019Withdrawn
Condition(s):Small Cell Lung CancerLast Updated:October 19, 2017Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.